Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Tianjin Tianyao Pharmaceuticals Co Ltd
600488Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. Its primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as dosage forms, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets. It also exports its products to the United States, Southeast Asia, Europe, South America, Africa, and internationally. The company was founded in 1999 and is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. operates as a subsidiary of Tianjin Pharmaceutical Group Co., Ltd. Address: No. 19, Xinye Ninth Street, Tianjin, China, 300462
Analytics
Zielpreis von Wall Street
40.48 CNYKGV
31.7857Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 600488
Dividenden-Analyse 600488
Dividendenwachstum über 5 Jahre
-72 %Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
49 %Verlauf der Dividende 600488
Bewertung der Aktie 600488
Finanzen 600488
Ergebnisse | 2019 | Dynamik |